If you are interested in hereditary cancer research, and/or the clinical management of hereditary tumour syndromes, then joining the EHTG offers you an active platform for collaborative studies and lively discussions.
At our meetings, you can experience a very open atmosphere, present your own results and opinions, and take part in the discussion on how to translate knowledge to clinical guidelines. While any institution and country may have local arguments to consider for these guidelines, our goal is to listen to and learn from each other to arrive at positions we all may agree upon.
This is to the benefit of all patients and families with a genetic predisposition to cancer. EHTG members can easily reach out to potential collaborators at the conferences and through the membership directory. Membership also offers the benefits of discounted conference rates, full access to posted meeting content including videos of presentations, to e-newsletters, webinars and to other informational material. We look forward to welcoming you at our annual meetings!
The annual membership is automatically renewed by July 1st of each year, unless cancelled 14 days ahead of this date (June 15 of each year).
All members will then receive the new membership invoice for the current and upcoming EHTG financial year from email@example.com end of June. After receipt of your payment, you will automatically receive the new access codes for the membership area.
If you do not want to renew, please actively cancel your membership by sending an informal mail to firstname.lastname@example.org before June 15.
If you decide to leave, please let us know why and remember that we wish to improve, so let us know your reasons.
Registration for the 8th annual EHTG meeting 2024 is now open! Membership includes the ONLINE participation of the meeting.
All accepted abstract authors/presenters are expected to be or become a member, latest at the deadline of submission of the prerecorded presentation.
All participants from low-income countries will receive a 50% waiver applying to all fees.
The Abstract submission for the 2024 event will open shortly.
+49 (0)160 84 59 502